Identification of a novel c-Myc inhibitor with antitumor effects on multiple myeloma cells

Scriptaid inhibits cell survival, cell cycle, and promotes apoptosis in multiple myeloma via epigenetic regulation of p21

(2018) Ruosi Yao et al.   EXPERIMENTAL HEMATOLOGY

Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3β and F-box and WD repeat domain-containing 7

(2018) Ji Hoon Jung et al.   ONCOGENE

Myc is also the bad guy in myeloma

(2016) Elisabet E. Manasanch   LEUKEMIA & LYMPHOMA

Overexpression of c-myc is associated with adverse clinical features and worse overall survival in multiple myeloma

(2016) Agoston Gyula Szabo et al.   LEUKEMIA & LYMPHOMA

Frontline therapy of multiple myeloma

(2015) P. Moreau et al.   BLOOD

Novel therapeutic strategies for multiple myeloma

(2015) Naoya Mimura et al.   EXPERIMENTAL HEMATOLOGY

Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling

(2015) Fabrizio Accardi et al.   Biomed Research International

Oncogene addiction to c-MYC in myeloma cells

(2015) Toril Holien et al.   Oncotarget

GSK-3 as potential target for therapeutic intervention in cancer

(2015) James A. McCubrey et al.   Oncotarget

PRMT7 Induces Epithelial-to-Mesenchymal Transition and Promotes Metastasis in Breast Cancer

(2014) R. Yao et al.   CANCER RESEARCH

International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation

(2014) Antonio Palumbo et al.   JOURNAL OF CLINICAL ONCOLOGY

Potassium channels in cell cycle and cell proliferation

(2014) D. Urrego et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Pin1 Regulates the Dynamics of c-Myc DNA Binding To Facilitate Target Gene Regulation and Oncogenesis

(2013) A. S. Farrell et al.   MOLECULAR AND CELLULAR BIOLOGY

Pharmacophore identification of c-Myc inhibitor 10074-G5

(2012) Jeremy L. Yap et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Addiction to c-MYC in multiple myeloma

(2012) T. Holien et al.   BLOOD

Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma

(2011) W-J Chng et al.   LEUKEMIA

Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells

(2011) N E Franke et al.   LEUKEMIA

Apoptotic signaling by c-MYC

(2008) B Hoffman et al.   ONCOGENE